Merck Evolves Structure to Enhance Commercial Execution and Portfolio Growth In an industry where the pace of innovation and market dynamics are constantly evolving, how can pharmaceutical companies ensure they stay ahead? Merck known as MSD outside of the United…
Positive Phase 3 Data Demonstrate Potential for ENTYVIO® (vedolizumab) to Address Treatment Gap for Children and Adolescents with Moderate to Severe Ulcerative Colitis Takeda today announced positive data from the pivotal Phase 3 KEPLER trial, which demonstrated that ENTYVIO® (vedolizumab) can offer…
NexEos Bio Announces FDA Clearance of IND Application to Proceed to Phase II/III Trial of NTX-1024 in Vernal Keratoconjunctivitis NexEos Bio Vision Health a clinical-stage biopharmaceutical company developing novel therapies and diagnostics targeting eosinophil-mediated diseases, today announced that the U.S.…
YolTech Therapeutics Announces Positive Interim Data on YOLT-202 for the Treatment of Alpha-1 Antitrypsin Deficiency YolTech Therapeutics, a late clinical-stage biotechnology company developing in vivo gene editing therapies, today announced positive interim data from an investigator-initiated trial (IIT) of YOLT-202,…
Shufti Sets a New Benchmark for VideoIdent in the DACH Market Shufti, a global identity verification and compliance technology provider announced the expansion of its VideoIdent solution across Germany, Austria, and Switzerland (DACH region), addressing the operational pressure points that banks, payment…
Spruce Biosciences Announces Positive Type B Meetings with U.S. FDA for TA-ERT for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB) Spruce Biosciences, Inc. a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant…
NationsBenefits and Kinney Drugs Partner to Expand Flex Card Access for Rx and OTC Health Needs in New York NationsBenefits, the leading healthcare fintech and supplemental benefits platform, announced a new partnership with Kinney Drugs, a trusted, employee-owned pharmacy and retail…
Europe Oncology Genomics Tracker Captures Oncologist Perspectives Across Major European Markets – Data Report by DeciBio Consulting LLC A new survey-based Genomics Tracker focused on the EU-5 (France, Germany, Italy, Spain, and the United Kingdom) by DeciBio Consulting LLC provides updated insight into how…
Arintra Cuts Coding Costs by Nearly One-Third for Customers, Driving Industry-Leading Retention and 8X Revenue Growth Arintra, the leading GenAI-native autonomous medical coding platform for healthcare organizations, today announced it finished 2025 with eight times year-over-year revenue growth, driven by…
RxERP and p‑Chip Corporation Announce Licensing Agreement to Enable Embedded Unit‑Level Digital Identity for DSCSA Compliance and End‑to‑End Pharmaceutical Traceability RxERP, a cloud-hosted, pharmaceutical-first ERP platform, and p‑Chip Corporation (“p‑Chip”), a provider of light-activated microtransponder tags and software for secure…
iProov Dynamic Liveness Is the First and Only Solution to Achieve CEN/TS 18099 High and Ingenium Level 4 for Injection Attack Detection iProov, the world’s leading provider of science-based biometric identity verification solutions, today announced that its Dynamic Liveness technology…
We Are All Sculptra: First-of-its-Kind Galderma Initiative to Demonstrate How Everyone Can Benefit from Sculptra’s Regenerative Properties Galderma the pure-play dermatology category leader, today unveiled We Are All Sculptra, a unique program designed to capture the clinical impact of Sculptra® across nine…